CSIMarket
 
Merck and Co Inc   (MRK)
Other Ticker:  
 
 
Price: $80.3474 $0.30 0.380%
Day's High: $81.16 Week Perf: -1.41 %
Day's Low: $ 80.31 30 Day Perf: 0.65 %
Volume (M): 1,414 52 Wk High: $ 92.64
Volume (M$): $ 113,718 52 Wk Avg: $81.66
Open: $80.61 52 Wk Low: $65.25



 Market Capitalization (Millions $) 203,708
 Shares Outstanding (Millions) 2,535
 Employees 70,000
 Revenues (TTM) (Millions $) 47,347
 Net Income (TTM) (Millions $) 11,538
 Cash Flow (TTM) (Millions $) -566
 Capital Exp. (TTM) (Millions $) 4,307

Merck And Co Inc
Merck & Co., Inc., is a global research-driven pharmaceutical products company that discovers, develops, manufactures and markets a broad range of innovative products to improve human and animal health, directly and through its joint ventures. The Company sells its products primarily to drug wholesalers and retailers, hospitals, clinics, government agencies and managed health care providers such as health maintenance organizations and other institutions. The Company’s professional representatives communicate the effectiveness, safety and value of its products to health care professionals in private practice, group practices and managed care organizations.


   Company Address: 2000 Galloping Hill Road Kenilworth 7033 NJ
   Company Phone Number: 740-4000   Stock Exchange / Ticker: NYSE MRK
   MRK is expected to report next financial results on January 28, 2021. Next quarterly dividend payout on January 07, 2021.
 

Merck And Co Inc 's Segments
 
Zocor
 Segment    0.57 % of total Revenue
Zetia
 Segment    6.48 % of total Revenue
CozaarHyzaar
 Segment    1.54 % of total Revenue
Singulair
 Segment    2.06 % of total Revenue
Proscar
 Segment    0.42 % of total Revenue
Isentress
 Segment    3.86 % of total Revenue
Primaxin
 Segment    0.77 % of total Revenue
Remicade
 Segment    4.52 % of total Revenue
Januvia
 Segment    10.38 % of total Revenue
Cancidas
 Segment    1.42 % of total Revenue
Other
 Segment    59.33 % of total Revenue
Merck Pharmaceutical
 Segment    91.34 % of total Revenue
Vaccines
 Segment    11.28 % of total Revenue
All Other
 Segment    8.66 % of total Revenue
 
  Company Estimates  
  Revenue Outlook
Merck And Co Inc announced annual revenue outlook on Jul. 28, 2015

Earnings Outlook
Merck and Co Inc issued annual earnings guidance on Jul. 28, 2015

 
Geographic Revenue Dispersion
United States 40.42 %
EMEA 31.19 %
Japan 8.22 %
Other 3.36 %
Asia Pacific 9.35 %
Latin America 7.46 %

Allstate Corp

Allstate Corp announced third quarter of 2019 operating profit of $2899 millions

For the third quarter of 2019 eps growth outpaced revenue increase, where profits soared by 46.72 % at $3.58 per share, Sales advanced by 3.19% to $11.50 billions from the same quarter a year ago.

In the previous quarter company realized Sales of $11.20 billions and bottom line of $3.86 per share.

Healthcare Realty Trust Incorporated

Healthcare Realty Trust Incorporated announced third quarter of 2019 operating surplus of $20.639 millions

Sales for the third quarter of 2019 increased by 7.68% to $125.25 millions in comparison to $116.32 millions on a year-over-year basis, company posted earnings growth of 100 % to $0.06, as comparison at $0.03 in the prior year quarter.

In contrast to the first quarter Sales increased by 0.36 % from $124.81 millions and eps soared by 100 % from $0.03 per share.

Copart Inc

Earnings Jumped by 29.69 %

Company achieved eps growth of 29.69 % to $0.83 in the first quarter of 2019, Sales increased by 9.28% to $592.94 millions in comparison to $542.58 millions in the prior year quarter.

compared to previous quarter earnings grew by 33.87 % from $0.62 per share and Sales advanced by 7.74 % from $550.36 millions.

Gentherm Incorporated

Gentherm Incorporated announced third quarter of 2019 operating profit of $38.506 millions

Gentherm Incorporated continued to show improvement in its results in the third quarter of 2019 compared to same quarter a year ago, eps grew by 812.5 % to $0.73 and Sales grew by 6.66% to $259.54 millions.

Sales advanced by 13.53 % from $228.61 millions in preceding period, eps more than doubled by 102.78 % from $0.36 per share.

Borgwarner Inc

Borgwarner Inc announced third quarter of 2019 operating surplus of $284 millions

Borgwarner Inc relized deterioration in earnings per share by -36.14% to $0.53 and Sales decrease by -0.67% to $2.53 billions in the third quarter of 2019, year on year.

From the preceding quarter, profits fell from $0.63 per share and Sales advanced by 11.19 % from $2.28 billions.






Customers Net Income grew by MRK's customers Net margin fell to 23.46 %
1.73 % 4.14 %
• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   
Major Competitors Stock performance

5 Days Decrease / Increase
     
BMY   -4.47%    
LLY        1.46% 
MYL   -100%    
ABT   -3.04%    
PFE   -2.69%    
JNJ   -4.02%    
• View Complete Report
   



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ZREITX's Profile

Stock Price

ZREITX's Financials

Business Description

Fundamentals

Charts & Quotes

ZREITX's News

Suppliers

ZREITX's Competitors

Customers & Markets

Economic Indicators

ZREITX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071